Köhler, B. C., Jassowicz, A., Scherr, A., Lorenz, S., Radhakrishnan, P., Kautz, N., . . . Schulze-Bergkamen, H. (2015). Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. Biomed Central.
Chicago Style (17th ed.) CitationKöhler, Bruno Christian, et al. Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling. London: Biomed Central, 2015.
MLA (9th ed.) CitationKöhler, Bruno Christian, et al. Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling. Biomed Central, 2015.
Warning: These citations may not always be 100% accurate.